orm 10-K for the fiscal year ended December 312007 and all our perio... Contact: ... Michael Watts ... Senior director investor relations and ... corporate communications ...
Date:5/19/2008
orm 10-K for the fiscal year ended December 31,
2007 and all our periodic filings made with the SEC. We assume no
obligation and expressly disclaim any duty to update any forward-looking
statement to reflect events or circumstances after the date of this news
release or to reflect the occurrence of subsequent events.
Contact:
Michael Watts
Senior director, investor relations and
corporate communications
858-410-8673
'/>"/>SOURCE Gen-Probe Incorporated Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
DermTech Appoints BioStatistical Pioneer, John Quackenbush, Ph.D., as a Member of the Companys Scientific Advisory Board2.
TopSpin Medical Appoints Cindy Setum, Ph.D., Vice President Clinical Affairs3.
Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development4.
WellGen, Inc. Names Nancy E. Rawson, Ph.D., Chief Scientific Officer5.
Neurobiological Technologies, Inc. Reports Retirement of Ronald E. Cape, Ph.D., from Board6.
Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer7.
Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Companys Board of Directors8.
Human Genome Sciences Appoints Maxine Gowen, Ph.D., to Its Board Of Directors9.
John E. Leonard, Ph.D., Former Biogen Idec Antibody Development Executive, Joins the Scientific Advisory Board of Vaccinex, Inc.10.
febit Appoints Michelle Lyles, Ph.D., Vice President, Marketing and Sales11.
RiverVest Venture Partners(R), a St. Louis-Based Venture Capital Firm Focusing on Life Sciences, Closes on Fund II, Names John P. McKearn, Ph.D., Venture Partner